Shots for kids near approval, more vaccine mandates go into effect, and the US's pandemic strategy evolves. Here's what you should know: Want to receive this weekly roundup and other coronavirus news? Yesterday Pfizer-BioNTech asked the FDA to issue an emergency use authorization for its vaccine in kids ages 5 to 11. The drugmakers are submitting relevant data, including information on how it will formulate the two pediatric doses, which are each one-third of those given to adults. The agency is tentatively scheduled to discuss this in an October 26 meeting, and a CDC advisory panel meeting has been scheduled for November 2 and 3, which means shots for children in this age group could be available shortly after that.